iBio Inc. Annual report pursuant to Section 13 and 15(d)

Significant Transactions - Summary of Asset Acquisition (Details) - RubrYc Therapeutics - USD ($)	Sep. 19, 2022	Aug. 23, 2021
Stock Purchase Agreement
Business Acquisition [Line Items]
Purchase price allocated		$ 7,500,000
Stock Purchase Agreement \| Preferred Stock
Business Acquisition [Line Items]
Purchase price allocated		1,760,000
Stock Purchase Agreement \| Intangible Assets
Business Acquisition [Line Items]
Purchase price allocated		4,300,000
Stock Purchase Agreement \| Prepaid Expenses
Business Acquisition [Line Items]
Purchase price allocated		$ 1,440,000
Asset Purchase Agreement
Business Acquisition [Line Items]
Purchase price allocated	$ 1,342,000
Asset Purchase Agreement \| Intangible Assets
Business Acquisition [Line Items]
Purchase price allocated	1,228,000
Asset Purchase Agreement \| Fixed Assets
Business Acquisition [Line Items]
Purchase price allocated	$ 114,000